A recent policy brief on CAR T-cell therapy includes ASCO’s principles for the approval, coverage, and reimbursement of the treatment. The principles aim to improve patient and provider access to CAR T-cell therapy.  

In the latest ASCO in Action Podcast, ASCO CEO Dr. Clifford A. Hudis is joined by Dr. Jeffrey Ward, a leading contributor to the society’s updated Patient-Centered Oncology Payment (PCOP) model, to discuss how PCOP can improve patient care and lower costs. 

Ten oncology practices from rural and urban centers in the U.S. that primarily treat underserved populations have received grant funding from the Stavros Niarchos Foundation to participate in ASCO’s Quality Oncology Practice Initiative (QOPI®) and Quality Training Program.